ALZcure is pioneering blockchain-powered funding for Alzheimer's research through Decentralized Science (DeSci). Built on ...
Researchers have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's disease.
Interesting Engineering on MSN7h
Breakthrough protein discovery may unlock new treatments for COVID-19, Alzheimer’sResearchers found that ArfGAP2 appears to play a key role in both normal immune responses and harmful overactivity.
Microglia, the brain's immune cells, usually serve as diligent guardians. They eliminate intruders such as microbes and clear ...
GlobalData on MSN16h
IGC adds new clinical site in Canada for Alzheimer’s agitation therapy trialIGC Pharma has added HHS in Canada as a new clinical site for its Phase II CALMA trial of IGC-AD1 to treat agitation in ...
In an international research collaboration involving the University Medical Center Göttingen (UMG), researchers have produced ...
A protein that impacts Alzheimer’s disease offers new opportunities for targeted treatments, although its cell-specific ...
And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been ...
ScienceAlert on MSN1d
Weight Loss Drug Semaglutide Shows Promise as Alzheimer's TreatmentScientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a ...
News-Medical.Net on MSN4d
IL-12 targeting could open pathways for new Alzheimer's treatmentsResearchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer's ...
INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback